The Pathway to a Universal Influenza Vaccine

Catharine I. Paules; Hilary D. Marston; Robert W. Eisinger; David Baltimore; Anthony S. Fauci

doi:10.1016/j.immuni.2017.09.007

The Pathway to a Universal Influenza Vaccine

Catharine I. Paules, Hilary D. Marston, Robert W. Eisinger, David Baltimore, Anthony S. Fauci

Research output: Contribution to journal › Article › peer-review

136 Scopus citations

Abstract

Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

Original language	English (US)
Pages (from-to)	599-603
Number of pages	5
Journal	Immunity
Volume	47
Issue number	4
DOIs	https://doi.org/10.1016/j.immuni.2017.09.007
State	Published - Oct 17 2017

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.immuni.2017.09.007

Cite this

@article{69423d772fe64a97aacf3459df81434f,

title = "The Pathway to a Universal Influenza Vaccine",

abstract = "Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.",

author = "Paules, {Catharine I.} and Marston, {Hilary D.} and Eisinger, {Robert W.} and David Baltimore and Fauci, {Anthony S.}",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2017",

month = oct,

day = "17",

doi = "10.1016/j.immuni.2017.09.007",

language = "English (US)",

volume = "47",

pages = "599--603",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - The Pathway to a Universal Influenza Vaccine

AU - Paules, Catharine I.

AU - Marston, Hilary D.

AU - Eisinger, Robert W.

AU - Baltimore, David

AU - Fauci, Anthony S.

PY - 2017/10/17

Y1 - 2017/10/17

N2 - Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

AB - Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

UR - http://www.scopus.com/inward/record.url?scp=85032837562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032837562&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2017.09.007

DO - 10.1016/j.immuni.2017.09.007

M3 - Article

C2 - 29045889

AN - SCOPUS:85032837562

SN - 1074-7613

VL - 47

SP - 599

EP - 603

JO - Immunity

JF - Immunity

IS - 4

ER -

The Pathway to a Universal Influenza Vaccine

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this